NCT03889795View on ClinicalTrials.gov

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 5, 2019

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2027

Conditions
Advanced Pancreatic CancerAdvanced Solid Tumor
Interventions
DRUG

Metformin

Metformin oral pill will be taken daily at breakfast (cohort 1) and breakfast and dinner (cohort 2 and 3).

DRUG

Simvastatin

Simvastatin oral pill will be taken daily in the evening.

DRUG

Digoxin

Digoxin oral pill will be taken once daily.

Trial Locations (1)

43614

University of Toledo, Eleanor N. Dana Cancer Center, Toledo

All Listed Sponsors
lead

Danae Hamouda, MD

OTHER